1. Small Nucleolar RNAs Determine Resistance to Doxorubicin in Human Osteosarcoma
   Martina Godel et al, 2020, International Journal of Molecular Sciences CrossRef
2. Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies
   Ingrid Lilienthal et al, 2020, International Journal of Molecular Sciences CrossRef
3. Mechanisms of Resistance to Conventional Therapies for Osteosarcoma
   Louise Marchandet et al, 2021, Cancers CrossRef
4. The role of ABC-transporters in homeostasis, cancer pathogenesis and therapy
   S. V. Boichuk et al, 2024, Advances in Molecular Oncology CrossRef
5. Impact of ABC Transporters in Osteosarcoma and Ewing’s Sarcoma: Which Are Involved in Chemoresistance and Which Are Not?
   Massimo Serra et al, 2021, Cells CrossRef
6. ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human Osteosarcoma
   Dimas Carolina Belisario et al, 2020, Cells CrossRef
7. Exosomal Long Non-Coding RNA ANCR Mediates Drug Resistance in Osteosarcoma
   Xin Hu et al, 2022, Frontiers in Oncology CrossRef
8. CD44 Contributes to the Regulation of MDR1 Protein and Doxorubicin Chemoresistance in Osteosarcoma
   Monserrat Gerardo-Ramírez et al, 2022, International Journal of Molecular Sciences CrossRef
9. In Reply
   Cindy L. Schwartz et al, 2007, Journal of Clinical Oncology CrossRef
10. Prognostic Value of P-Glycoprotein in High-Grade Osteosarcoma
    Massimo Serra et al, 2007, Journal of Clinical Oncology CrossRef
11. Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcoma
    Ilaria Buondonno et al, 2019, Cellular and Molecular Life Sciences CrossRef